Altimmune and the University of Alabama at Birmingham (UAB) Announce Positive Preclinical Results for Intranasal COVID-19 Vaccine Candidate, AdCOVID™
Go back to Altimmune and the University of Alabama at Birmingham (UAB) Announce Positive Preclinical Results for Intranasal COVID-19 Vaccine Candidate, AdCOVID™| iShares Diversified Alternatives Trust (NASDAQ: ALT) | Delayed: 3.25 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.25 | 52 Week High | $54.24 | |||
| Open | $3.25 | 52 Week Low | $48.35 | |||
| Day High | $3.25 | P/E | N/A | |||
| Day Low | $3.25 | EPS | $0.00 | |||
| Volume | 2,296 | |||||
